NOVAPAK Nasal Packing in Shellfish Allergic Patients

Phase

Condition

Allergy

Allergies & Asthma

Treatment

NOVAPAK nasal packing applied to nasal cavity

NOVAPAK nasal packing applied to forearm

Clinical Study ID

NCT05343650

ReDA 12329

Ages 18-60
All Genders
Accepts Healthy Volunteers

Study Summary

NOVAPAK is a sponge-like material made from materials found in shellfish. It is commonly used after nasal surgery or in nasal bleeding, as it promotes healing, decreases bleeding, and has antibacterial properties. Although NOVOPAK does not contain proteins or compounds known to be responsible for allergic reactions in people with a known allergy to shellfish, out of an abundance of caution, the manufacturer (Medtronic) has recommended avoidance in those with known shellfish allergy. There have been no reported allergic reactions in patients with shellfish allergy who were given chitosan bandages in emergencies (e.g. military applications). The study aims to investigate the safety of its use in patients with known shellfish allergy to improve healthcare quality and patient care support.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Adults aged 18-60
Positive history of shellfish allergy
Confirmation of allergy via previous reaction during oral challenge or convincingclinical history and testing.

Exclusion

Exclusion Criteria:

Severe lung diseases: severe asthma, obstructive lung disease
Severe cardiovascular disease: history of congestive heart failure, myocardialinfarction, valvulopathy, or unstable tachy-or-bradyarrhythmia.
Severe cerebrovascular disease: history of stroke or severe carotid stenosis.
Presence of beta-blocker mediations.
Patients unable to discontinue antihistamine medications or prednisone.
Patients with severe or refractory anaphylaxis during prior oral challenge toshellfish, or those with documented systemic mastocytosis.
Pregnancy

Study Design

NOVAPAK nasal packing applied to nasal cavity

March 15, 2024

May 15, 2025

Study Description

This is a prospective interventional study to assess whether the tested product triggers an allergic reaction in patients with known-shellfish allergies.

The primary objective is to assess the safety of Novapak, a chitosan-containing nasal packing material, in patients with known shellfish allergy.

The study will be conducted in two phases. First, participants will undergo an allergy test - Skin prick test (SPT) to crab, lobster, shrimp, oyster, clam, scallop, squid, and octopus -, and antibody levels analysis. Second, in a controlled setting (i.e., in a hospital clinic that includes a resuscitation cart and doctors monitoring - allergist and otolaryngologist), Novapak packing will be applied to the patient's skin for 30 minutes (on the anterior aspect of the patients' non-dominant arm). Then, provided that no allergic symptoms are observed in stage 1, the patient's nose will be anesthetized with topical lidocaine, and a piece of Novapak material will be applied to the participant's nasal cavity at the level of the inferior turbinate for 15 minutes. After removal, the participant will be monitored in the clinic for an hour. Any allergic reaction will be documented, including increased nasal congestion, rhinorrhea, or pruritis.

Since Novapak contains purified chitosan, the investigators hypothesizes that no allergic reactions will be demonstrated.

Connect with a study center

St. Joseph's Health Care
London, Ontario N5A 4V2
Canada
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.